As ordered reported by the House Committee on Veterans’ Affairs on December 5, 2023
To enhance its work for the Congress, CBO is looking for new research that examines how changes in pharmaceutical companies’ expected future profits affect the development of new drugs and health outcomes.
As ordered reported by the House Committee on Foreign Affairs on November 29, 2023
